NAFLD NGM282 Market Size and Forecast The Non-Alcoholic Fatty Liver Disease (NAFLD) drug market, which NGM282 is targeting, is substantial. The overall market size was estimated at around USD 20.97 billion in…
T1D Stem Cell Tx Market: Size, Forecast, Drivers, and Key Trends
T1D Stem Cell Therapy Market Size and Forecast The global Type 1 Diabetes (T1D) Stem Cell Therapy market is positioned for significant expansion, driven by the promise of a functional cure for…
pJIA Ustekinumab Market: Size, Forecast, Drivers, and Key Trends
pJIA Ustekinumab Market Size and Forecast The Ustekinumab market segment for polyarticular Juvenile Idiopathic Arthritis (pJIA) is a specialized, niche sector within the broader biologics landscape. The market size is tied to…
HS Ifabotuzumab Market: Size, Forecast, Drivers, and Key Trends
HS Ifabotuzumab Market Size and Forecast As a specialized monoclonal antibody (MAb) candidate, the market size for HS Ifabotuzumab is currently defined by its positioning within the broader, high-growth cancer monoclonal antibodies…
AS Ustekinumab Market: Size, Forecast, Drivers, and Key Trends
Ustekinumab for AS Market Size and Forecast Ustekinumab, marketed as Stelara, is a major biologic drug used for treating various autoimmune conditions, including Ankylosing Spondylitis (AS), where it targets IL-12 and IL-23…
RA Masitinib Market: Size, Forecast, Drivers, and Key Trends
RA Masitinib Market Size and Forecast Masitinib, a potent oral tyrosine kinase inhibitor (TKI), is under investigation for Rheumatoid Arthritis (RA) treatment, aiming to modulate immune cell function crucial in RA pathogenesis….
RET Pralsetinib Thyroid Market: Size, Forecast, Drivers, and Key Trends
RET Pralsetinib Thyroid Market Size and Forecast The market specifically addresses Ret-altered thyroid cancers, primarily medullary thyroid cancer (MTC) and non-MTC papillary thyroid cancer (PTC). Pralsetinib, marketed as Gavreto, is a highly…
NTRK Vusigdifim Market: Size, Forecast, Drivers, and Key Trends
NTRK Fusion Gene Positive Advanced Solid Tumor Market Size and Forecast The NTRK fusion gene positive advanced solid tumor market addresses a rare but significant oncological need, driving demand for targeted therapies…
MSI Toripalimab Market: Size, Forecast, Drivers, and Key Trends
MSI Toripalimab Market Size and Forecast The market for MSI Toripalimab (LOQTORZI) is defined by its role as an advanced PD-1 immunotherapy, initially approved for Nasopharyngeal Carcinoma (NPC) in specific settings. While…
BRAF Binimetinib Market: Size, Forecast, Drivers, and Key Trends
BRAF/Binimetinib Market Size and Forecast The market for BRAF/MEK inhibitor combinations, including Binimetinib (Mektovi) often combined with Encorafenib (Braftovi), is a critical segment within the targeted oncology space. This combination is essential…